483 Document: KBI Biopharma, Inc., Dec 3, 2021

FDANews 483 KBI Biopharma, Inc. Dec 3 2021 top
Nicholas L. Hunt FDA Investigator Michael A. Charles FDA Investigator

On Dec 03, 2021, the FDA inspected KBI Biopharma, Inc.'s Boulder site. Explore the inspectional observations.